
    
      Potential subjects came to the for a screening visit. Eligible subjects had baseline
      assessments performed and were provided study medication, allantoin 3% cream. Subjects were
      instructed to apply the study medication to the entire body once daily and to keep daily
      record of study medication use. Subjects returned every 4 weeks for a total of 12 weeks for
      repeat assessments.
    
  